当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 资产负债表

海尔生物

(688139)

  

流通市值:98.25亿  总市值:98.25亿
流通股本:3.18亿   总股本:3.18亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金831,055,160.95901,227,075.69983,791,234.621,151,899,865.06
应收票据及应收账款444,649,434.93330,991,696.12447,310,936.31393,451,647.22
其中:应收票据12,751,992.997,145,875.337,350,475.791,708,273.56
应收账款431,897,441.94323,845,820.79439,960,460.52391,743,373.66
应收款项融资14,862,320.1512,418,141.22446,407.89,989,221.36
预付款项20,042,685.0627,267,096.1619,950,887.6319,290,706.62
其他应收款合计7,810,091.818,556,956.918,234,663.149,301,742.7
存货303,739,515.42334,744,974.95258,026,061.32244,993,394.53
合同资产9,200,569.819,348,923.995,205,741.831,789,666.34
一年内到期的非流动资产327,082,511.02126,539,483.6351,825,683.8151,235,412.36
其他流动资产10,062,997.8124,103,642.1419,853,470.3521,158,796.47
流动资产平衡项目0000
流动资产合计2,863,421,109.962,652,447,941.352,660,812,428.82,405,604,989.66
非流动资产:
长期股权投资183,880,063.55137,987,031.94134,806,348.12133,181,471.47
其他权益工具投资41,397,596.4741,397,596.4728,199,861.6528,199,861.65
其他非流动金融资产9,000,0009,000,0009,000,0009,000,000
投资性房地产8,660,741.258,857,663.479,045,063.759,241,985.97
固定资产791,880,590.41807,291,286.02802,356,927.99810,585,608.69
在建工程101,101,731.595,034,029.2596,950,701.6577,351,106.94
使用权资产11,548,025.6712,854,331.7914,016,749.2112,539,069.54
无形资产392,870,662.41402,302,641.03413,962,989.63425,371,371.98
商誉758,097,771.67757,866,205.38758,169,731.51757,755,028.67
长期待摊费用6,331,467.56,715,7066,516,454.136,713,900.47
递延所得税资产66,673,482.5566,008,575.0562,490,424.7462,592,740.56
其他非流动资产595,577,358.5789,705,787.26645,367,055.64848,584,539.19
非流动资产平衡项目0000
非流动资产合计2,967,019,491.483,135,020,853.662,980,882,308.023,181,116,685.13
资产平衡项目0000
资产总计5,830,440,601.445,787,468,795.015,641,694,736.825,586,721,674.79
流动负债:
短期借款10,007,777.7810,009,027.7819,096,331.8221,104,670.4
应付票据及应付账款466,777,643.97427,598,354.67434,231,479.44423,326,041.66
其中:应付票据105,880,065.9190,192,201.48102,814,580.99110,535,492.82
应付账款360,897,578.06337,406,153.19331,416,898.45312,790,548.84
合同负债85,129,205.55151,984,833.7461,621,731.0955,794,947.72
应付职工薪酬66,785,937.3983,940,305.4782,845,494.4573,356,340.12
应交税费51,878,400.3750,913,525.4551,236,833.5151,768,970.32
其他应付款合计262,472,171.51273,354,626.83276,454,629.34289,181,966.93
一年内到期的非流动负债13,126,023.0313,204,768.6317,396,747.1915,954,925.15
其他流动负债10,729,877.3711,398,099.945,958,435.76,144,161.86
流动负债平衡项目0000
流动负债合计966,907,036.971,022,403,542.51948,841,682.54936,632,024.16
非流动负债:
长期借款10,007,222.22---
租赁负债7,018,616.987,432,212.618,766,942.327,597,964.98
长期应付款55,929,429.3255,252,585.1654,607,357.1653,962,129.16
预计负债8,560,784.758,560,784.755,596,795.145,596,795.14
递延收益22,352,884.6223,168,795.8927,328,207.1828,536,368.41
递延所得税负债50,863,349.8352,514,841.355,078,023.956,829,367.66
非流动负债平衡项目0000
非流动负债合计154,732,287.72146,929,219.71151,377,325.7152,522,625.35
负债平衡项目0000
负债合计1,121,639,324.691,169,332,762.221,100,219,008.241,089,154,649.51
所有者权益(或股东权益):
实收资本(或股本)317,952,508317,952,508317,952,508317,952,508
资本公积1,978,331,416.731,977,335,357.141,975,507,012.431,989,000,700.16
减:库存股167,204,433.14140,197,717.52140,197,717.52125,409,937.49
其他综合收益-2,236,031.38-2,693,310.15-13,291,752.57-14,079,617.69
盈余公积158,976,254158,976,254158,976,254158,976,254
未分配利润2,170,435,659.892,060,177,419.542,002,686,468.811,927,887,457.5
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,456,255,374.14,371,550,511.014,301,632,773.154,254,327,364.48
少数股东权益252,545,902.65246,585,521.78239,842,955.43243,239,660.8
股东权益平衡项目0000
股东权益合计4,708,801,276.754,618,136,032.794,541,475,728.584,497,567,025.28
负债和股东权益合计5,830,440,601.445,787,468,795.015,641,694,736.825,586,721,674.79
公告日期2025-04-302025-03-292024-10-302024-08-23
审计意见(境内)标准无保留意见
TOP↑